Anna Jeter
About Anna Jeter
Anna Jeter is a Chief Regulatory Officer and Co-Founder, recognized for her pioneering work in early cancer detection and her influential role in global healthcare regulations.
Anna Jeter Chief Regulatory Officer & Co-Founder
Anna Jeter is the Chief Regulatory Officer and Co-Founder of her organization. She plays a crucial role in guiding the company's regulatory strategy and compliance efforts. Jeter leverages her extensive experience in regulatory affairs to ensure that the company's products meet both national and international standards. Her leadership has been pivotal in driving the organization's mission to deliver innovative diagnostic solutions.
Anna Jeter Inc. Magazine's 2022 Female Founders 100 List
In 2022, Anna Jeter was recognized by Inc. Magazine as one of the top 100 Female Founders. This accolade highlights her significant contributions to the field and acknowledges her role in leading and co-founding a company that is making strides in early cancer detection and diagnostic technologies. The recognition underscores her impact and leadership in a highly competitive and innovative industry.
Anna Jeter GlycoLocateTM Platform for Early Cancer Detection
Anna Jeter is a pioneering force behind the development of the GlycoLocateTM platform, which focuses on early cancer detection. This innovative platform represents a significant advancement in the field of diagnostics, aiming to identify cancer at its earliest stages. Jeter's work on GlycoLocateTM exemplifies her commitment to leveraging cutting-edge technology to improve patient outcomes and advance medical diagnostics.
Anna Jeter National and Pan-European Guidelines Inclusion
Anna Jeter oversees the inclusion of multiple products in national and pan-European guidelines. Her dedication ensures that the company's diagnostic solutions are recognized and integrated into key regulatory frameworks across multiple regions. This effort not only validates the quality and efficacy of the products but also facilitates their acceptance and use in diverse healthcare settings.
Anna Jeter US FDA Submissions Experience
Anna Jeter brings significant experience with US FDA submissions, navigating various regulatory routes such as 510(k), PMA, and CLIA LTD. Her expertise in these processes ensures that the company's products comply with stringent regulatory requirements, thereby facilitating their timely approval and market entry. Jeter's proficiency in regulatory submissions underscores her pivotal role in the organization's success.
Anna Jeter Launching Diagnostics in Global Markets
Anna Jeter has led teams in launching paradigm-changing diagnostics in women's health across Europe, the Middle East, Latin America, and Asia. Her leadership and strategic oversight have enabled the company to introduce innovative diagnostic solutions in these diverse markets. Jeter's global experience and understanding of regional regulatory and market dynamics are key to the company's international expansion and adoption of its products.